Those considering Tirzepatide for weight loss should be aware of its administration as a once-weekly subcutaneous injection, which may be accompanied by common side effects such as nausea, diarrhea, and injection site reactions. The medication's dosage should be gradually increased to minimize side effects. Tirzepatide has been approved for chronic weight management in adults with obesity or overweight conditions in conjunction with a reduced-calorie diet and increased physical activity.
Further Reading:
1. “Tirzepatide Enhances Weight Loss with Sustained Treatment but Discontinuation Leads to Weight Regain.” WCM Newsroom. https://news.weill.cornell.edu/news/2023/12/tirzepatide-enhances-weight-loss-with-sustained-treatment-but-discontinuation-leads-to. Accessed 18 Mar. 2024.
2. “Tirzepatide (Subcutaneous Route) Side Effects - Mayo Clinic.” www.mayoclinic.org/drugs-supplements/tirzepatide-subcutaneous-route/side-effects/drg-20534045.
3. Farzam, Khashayar, and Preeti Patel. “Tirzepatide.” PubMed, StatPearls Publishing, 2022. www.ncbi.nlm.nih.gov/books/NBK585056/.
4. “Tirzepatide Subcutaneous: Uses, Side Effects, Interactions, Pictures, Warnings & Dosing - WebMD.” www.webmd.com/drugs/2/drug-184157/tirzepatide-subcutaneous/details.
5. Palmer, Christina. “Can Tirzepatide Help You Lose Weight?” GoodRx, 18 Oct. 2022. www.goodrx.com/conditions/weight-loss/tirzepatide-and-weight-loss.